PRL-8-53 – Solution, 600mg (20mg/mL)

$14.99

PRL-8-53 – Solution, 600mg (20mg/mL) is a premium laboratory-grade research compound classified as a substituted phenethylamine, presented as a clear liquid solution in DMSO at 20mg/mL concentration (30mL total volume). This synthetic nootropic compound (CAS 51352-88-6), first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s, has been shown to act as a hypermnesic drug in humans, enhancing learning and retention of verbal information for in vitro/in vivo modeling and analytical testing applications. Available for fast, compliant shipping to all U.S. states and European countries.

  • Lot-coded with public third-party lab reports guaranteeing absolute transparency and verified purity ≥98%

  • Formulation completely free of adulterants, excipients, flow agents, and additives for raw chemical purity

  • Includes convenient graduated pipette for precise measurement ensuring accuracy in analytical testing

  • Chemically stable DMSO solution with tamper-proof sealing ensures transit safety and research application integrity

Category:
Description

PRL-8-53 – 600mg (20mg/mL) Solution

This premium laboratory-grade research compound delivers a clear liquid solution at 20mg/mL concentration with ≥98% purity verified by analytical testing. PRL-8-53 represents a synthetic nootropic substituted phenethylamine derived from benzoic acid and phenylmethylamine, offering technical value to modern scientific investigators studying memory enhancement, learning improvement, hypermnesic effects, short-term memory enhancement, mental clarity, and cognitive function in in vitro/in vivo modeling research application.

We proudly fulfill all U.S. orders directly from primary United States production facilities for domestic speed, while European and international orders utilize our dedicated United Kingdom shipping hub to ensure seamless, efficient customs clearance across the UK and continental Europe throughout all 50 U.S. states and European countries.

  • Lot-coded material with public third-party lab reports providing absolute transparency for every batch

  • Zero adulterants, excipients, or flow agents guarantee raw chemical purity for investigators

  • Precision concentration at 20mg/mL ensures consistency for analytical testing procedures

  • DMSO solution formulation with graduated pipette and tamper-proof seal engineered for transit safety


Technical Specifications & Chemical Profile

Chemical Property Specification Data
Product Name PRL-8-53 (Solution)
Common Synonyms Methyl 3-(2-(benzylmethylamino)ethyl)benzoate hydrochloride, 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride, 3-(2-(Methyl(phenylmethyl)amino)ethyl)benzoic acid methyl ester hydrochloride, (2-dimethylaminoethyl) benzhydryl methylcarbamate hydrochloride, AC1L22UR, CTK4J4081, LS-36115, methyl amino ethyl benzoate
CAS Number 51352-88-6
Molecular Formula C₁₈H₂₂ClNO₂
Molar Mass 319.83 g/mol
Primary Target Mechanism Hypermnesic drug; substituted phenethylamine; possible cholinergic properties; potentiates dopamine; partially inhibits serotonin; memory enhancement; learning improvement; cognitive processing enhancement
Physical Form Clear liquid solution in DMSO

Research Applications & Storage Protocols

Hypermnesic Substituted Phenethylamine & Memory Enhancement Profile

PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans, first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters. The exact mechanism of action remains unknown, but it displays possible cholinergic properties, potentiates dopamine while partially inhibiting serotonin, and reverses the catatonic and ptotic effects of reserpine. One human study on PRL-8-53 confirmed its potency as a memory enhancer, demonstrating the ability to enhance learning and help in retaining verbal information with statistically significant improvement (most P values better than 0.01, some better than 0.001). The compound is relatively non-toxic with an oral LD₅₀ in mice of 860 mg/kg, giving the drug a high therapeutic index. Research demonstrates hypermnesic effects without stimulant properties at doses up to 200 mg/kg for in vitro/in vivo modeling applications.

Handling & Storage Guidelines

  • Long-Term Storage: Store at -20°C for DMSO solution (6 months stability); keep in desiccated conditions away from heat, light, and moisture; minimize contact with open air

  • Solubility: Soluble in DMSO (already in DMSO solution at 20mg/mL); 10 mM stock solution preparation available for additional analytical testing

  • Appearance: Clear liquid, solution in DMSO with standard organoleptic profile

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.

Additional information
pa_feature

Discountinued

pa_form

Liquids

pa_types

Peptides

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “PRL-8-53 – Solution, 600mg (20mg/mL)”